
Shantell Laketa Heiber
Examiner (ID: 4200, Phone: (571)272-0886 , Office: P/2641 )
| Most Active Art Unit | 2645 |
| Art Unit(s) | 2641, 2644, 2645, 2617 |
| Total Applications | 943 |
| Issued Applications | 655 |
| Pending Applications | 110 |
| Abandoned Applications | 212 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6971307
[patent_doc_number] => 20050037017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins'
[patent_app_type] => utility
[patent_app_number] => 10/938695
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16140
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037017.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938695
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938695 | Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins | Sep 9, 2004 | Issued |
Array
(
[id] => 731502
[patent_doc_number] => 07037507
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-02
[patent_title] => 'T helper cell epitopes'
[patent_app_type] => utility
[patent_app_number] => 10/935155
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8413
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/037/07037507.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935155
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935155 | T helper cell epitopes | Sep 7, 2004 | Issued |
Array
(
[id] => 7230772
[patent_doc_number] => 20050079182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Immunogenic compositions of human papillomavirus and sera produced therefrom'
[patent_app_type] => utility
[patent_app_number] => 10/935536
[patent_app_country] => US
[patent_app_date] => 2004-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8917
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20050079182.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935536
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935536 | Immunogenic compositions of human papillomavirus and sera produced therefrom | Sep 6, 2004 | Abandoned |
Array
(
[id] => 7074355
[patent_doc_number] => 20050147623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Recombinant parainfluenza virus expression systems and vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/934864
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17570
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20050147623.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934864
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934864 | Recombinant parainfluenza virus expression systems and vaccines | Sep 2, 2004 | Issued |
Array
(
[id] => 606294
[patent_doc_number] => 07153659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-26
[patent_title] => 'HPV CD8+ T-cell epitopes'
[patent_app_type] => utility
[patent_app_number] => 10/924377
[patent_app_country] => US
[patent_app_date] => 2004-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15292
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/153/07153659.pdf
[firstpage_image] =>[orig_patent_app_number] => 10924377
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/924377 | HPV CD8+ T-cell epitopes | Aug 22, 2004 | Issued |
Array
(
[id] => 7142967
[patent_doc_number] => 20050118251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Novel DNA-based vaccine against the encephalitis alphaviruses'
[patent_app_type] => utility
[patent_app_number] => 10/921868
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8632
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118251.pdf
[firstpage_image] =>[orig_patent_app_number] => 10921868
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/921868 | DNA-based vaccine against the encephalitis alphaviruses | Aug 19, 2004 | Issued |
Array
(
[id] => 445522
[patent_doc_number] => 07252944
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-07
[patent_title] => 'Methods and compositions for modulating cell proliferation'
[patent_app_type] => utility
[patent_app_number] => 10/903334
[patent_app_country] => US
[patent_app_date] => 2004-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12624
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/252/07252944.pdf
[firstpage_image] =>[orig_patent_app_number] => 10903334
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/903334 | Methods and compositions for modulating cell proliferation | Jul 29, 2004 | Issued |
Array
(
[id] => 7159673
[patent_doc_number] => 20050084502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Equine herpesvirus vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/897984
[patent_app_country] => US
[patent_app_date] => 2004-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17564
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084502.pdf
[firstpage_image] =>[orig_patent_app_number] => 10897984
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/897984 | Equine herpesvirus vaccine | Jul 22, 2004 | Issued |
Array
(
[id] => 7126911
[patent_doc_number] => 20050058655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits'
[patent_app_type] => utility
[patent_app_number] => 10/891444
[patent_app_country] => US
[patent_app_date] => 2004-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15561
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058655.pdf
[firstpage_image] =>[orig_patent_app_number] => 10891444
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/891444 | Causative agent of the Mystery Swine Disease, vaccine compositions and diagnostic kits | Jul 13, 2004 | Issued |
Array
(
[id] => 7249780
[patent_doc_number] => 20040258708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Cytotoxic T-cell epitopes of papillomavirus L1 protein and their use in diagnostics and therapy'
[patent_app_type] => new
[patent_app_number] => 10/890526
[patent_app_country] => US
[patent_app_date] => 2004-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10373
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20040258708.pdf
[firstpage_image] =>[orig_patent_app_number] => 10890526
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/890526 | Cytotoxic T-cell epitopes of papillomavirus L1 protein and their use in diagnostics and therapy | Jul 12, 2004 | Abandoned |
Array
(
[id] => 529721
[patent_doc_number] => 07179619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-20
[patent_title] => 'Methods and compositions for inhibiting herpesviral replication'
[patent_app_type] => utility
[patent_app_number] => 10/885862
[patent_app_country] => US
[patent_app_date] => 2004-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11089
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/179/07179619.pdf
[firstpage_image] =>[orig_patent_app_number] => 10885862
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/885862 | Methods and compositions for inhibiting herpesviral replication | Jul 6, 2004 | Issued |
Array
(
[id] => 7261524
[patent_doc_number] => 20040241193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Novel composition'
[patent_app_type] => new
[patent_app_number] => 10/883126
[patent_app_country] => US
[patent_app_date] => 2004-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3307
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241193.pdf
[firstpage_image] =>[orig_patent_app_number] => 10883126
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/883126 | Composition | Jun 30, 2004 | Issued |
Array
(
[id] => 731507
[patent_doc_number] => 07037509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-02
[patent_title] => 'Immunologically significant herpes simplex virus antigens and methods for using same'
[patent_app_type] => utility
[patent_app_number] => 10/882074
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 22347
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/037/07037509.pdf
[firstpage_image] =>[orig_patent_app_number] => 10882074
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/882074 | Immunologically significant herpes simplex virus antigens and methods for using same | Jun 29, 2004 | Issued |
Array
(
[id] => 925606
[patent_doc_number] => 07316904
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-01-08
[patent_title] => 'Automated pap screening using optical detection of HPV with or without multispectral imaging'
[patent_app_type] => utility
[patent_app_number] => 10/881224
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 4305
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/316/07316904.pdf
[firstpage_image] =>[orig_patent_app_number] => 10881224
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/881224 | Automated pap screening using optical detection of HPV with or without multispectral imaging | Jun 29, 2004 | Issued |
Array
(
[id] => 7033128
[patent_doc_number] => 20050031637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Medicament for preventing or treating papilloma virus-specific tumor'
[patent_app_type] => utility
[patent_app_number] => 10/878231
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6794
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20050031637.pdf
[firstpage_image] =>[orig_patent_app_number] => 10878231
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/878231 | Medicament for preventing or treating papilloma virus-specific tumor | Jun 28, 2004 | Abandoned |
Array
(
[id] => 7275102
[patent_doc_number] => 20040234553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Cold-adapted equine influenza viruses'
[patent_app_type] => new
[patent_app_number] => 10/872014
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24822
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234553.pdf
[firstpage_image] =>[orig_patent_app_number] => 10872014
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/872014 | Cold-adapted equine influenza viruses | Jun 17, 2004 | Issued |
Array
(
[id] => 7276290
[patent_doc_number] => 20040235741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Human papilloma virus treatment'
[patent_app_type] => new
[patent_app_number] => 10/871138
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10465
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235741.pdf
[firstpage_image] =>[orig_patent_app_number] => 10871138
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/871138 | Human papilloma virus treatment | Jun 17, 2004 | Issued |
Array
(
[id] => 5206829
[patent_doc_number] => 20070028311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15'
[patent_app_type] => utility
[patent_app_number] => 10/559627
[patent_app_country] => US
[patent_app_date] => 2004-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5439
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20070028311.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559627 | Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15 | Jun 2, 2004 | Abandoned |
Array
(
[id] => 7034515
[patent_doc_number] => 20050033025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination'
[patent_app_type] => utility
[patent_app_number] => 10/858384
[patent_app_country] => US
[patent_app_date] => 2004-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10335
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20050033025.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858384
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858384 | Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination | Jun 1, 2004 | Issued |
Array
(
[id] => 7177701
[patent_doc_number] => 20050123902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Human papillomavirus inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/851407
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15456
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123902.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851407
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851407 | Human papillomavirus inhibitors | May 20, 2004 | Abandoned |